AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Fulgent Genetics, Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG00DW0QQM5
20.10▲ 0.11 (0.55%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
19.99
Day's Range
19.65 – 20.28
52-Week Range
13.45 – 31.04
Volume
239.6K
Avg Volume
296.3K
Share Statistics
Shares Outstanding
Employees
1,315
Exchange
XNAS
Listed
2016-09-29
Share count as of July 27, 2026

Fulgent Genetics, Inc. Common Stock (FLGT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Fulgent Genetics, Inc. Common Stock (FLGT)
What is Fulgent Genetics, Inc. Common Stock's Market Cap?
Fulgent Genetics, Inc. Common Stock's Market Cap is $553.1M, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's Enterprise Value?
Fulgent Genetics, Inc. Common Stock's Enterprise Value is $526.9M, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's Price / Sales?
Fulgent Genetics, Inc. Common Stock's Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's EV / Revenue?
Fulgent Genetics, Inc. Common Stock's EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's EV / EBITDA?
Fulgent Genetics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's Revenue (TTM)?
Fulgent Genetics, Inc. Common Stock's Revenue (TTM) is $323.9M, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's Net Income (TTM)?
Fulgent Genetics, Inc. Common Stock's Net Income (TTM) is -$84.4M, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's EBITDA?
Fulgent Genetics, Inc. Common Stock's EBITDA is -$96.5M, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's Diluted EPS (TTM)?
Fulgent Genetics, Inc. Common Stock's Diluted EPS (TTM) is -3.07, based on as-reported figures from SEC (XBRL) filings.
What is Fulgent Genetics, Inc. Common Stock's EBITDA Margin?
Fulgent Genetics, Inc. Common Stock's EBITDA Margin is -29.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · FLGTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Statement of Operations Data:
Revenue
YoY growth+4.4%-3.2%+9.3%+17.2%
Cost of revenue
Gross profit
% of revenue30.1%30.2%39.1%42.2%
Operating expenses
Research and development
Selling and marketing
General and administrative
Amortization of intangible assets
Intangible impairment loss———
Total operating expenses
% of revenue72.3%78.9%82.6%60.5%
Operating loss
% of revenue-42.2%-48.7%-43.5%-18.3%
Other income (expenses)
Interest income
Interest expense
Equity securities impairment loss—
Other income, net
Total other income (expense), net
Loss before income taxes
Provision for (benefit from) income taxes
Net loss from consolidated operations
% of revenue-34.8%-35.5%-28.4%-8.1%
Net loss attributable to noncontrolling interest
Net loss attributable to Fulgent
% of revenue-34.6%-34.9%-28.1%-7.9%